GSK3B and acute kidney injury: In complementary studies, therapeutic targeting of GSK3β was able to protect against kidney dysfunction and mitigate acute renal injury in animal models of acute glomerulopathy8 or AKI9, and improve the subsequent AKI to CKD transition31.